meRfi®-GM

GDF15 & Type 1 Diabetes (T1D)

Welcome to meRfi-GM!

meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Navigation

GDF15 is a potential preventative therapy against T1D progression
Sarkar et al. 2022 Expert Opinion on Therapeutic Targets 26(1): 57-67

Additionally, the effect of GDF15 in the induction of anorexia and nausea-like behavior and short-half-life present significant challenges to its deployment
Sarkar et al. 2022 Expert Opinion on Therapeutic Targets 26(1): 57-67
…

References (Sources)

GDF15: a potential therapeutic target for type 1 diabetes
Sarkar et al. 2022 Expert Opinion on Therapeutic Targets 26(1): 57-67
Review

meRfi®-GM

GDF15 & Type 1 Diabetes (T1D)

Welcome to meRfi-GM!

Navigation

Contents

References (Sources)